InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Jenkins John Kenneth. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 4 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €18k. History available since 30 May 2024. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Jenkins John Kenneth is a director at Corbus Pharmaceuticals Holdings, Inc. (XNAS). He has 4 filings in total, and across the 4 sampled filings the activity consists of sales, with sell volume of EUR 17986 between 2024-06-03 and 2026-06-11.